Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/12/2013US8580856 Acetaminophen/ibuprofen combinations and method for their use
11/12/2013US8580855 Acetaminophen / ibuprofen combinations and method for their use
11/12/2013US8580854 Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitors
11/12/2013US8580853 Analgesic composition and method of making the same
11/12/2013US8580852 2-oxamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudopeptides
11/12/2013US8580851 Ophthalmic solution
11/12/2013US8580850 Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
11/12/2013US8580849 Hydrous gel and production process and use of the hydrous gel
11/12/2013US8580848 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
11/12/2013US8580847 Antrocin containing pharmaceutical compositions for inhibiting cancer cells
11/12/2013US8580846 Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
11/12/2013US8580845 Functionalized expanded porphyrins
11/12/2013US8580844 Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
11/12/2013US8580843 Use of diindolylmethane (DIM) compounds and derivatives as neuroprotective agents
11/12/2013US8580841 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
11/12/2013US8580840 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
11/12/2013US8580839 Photosensitizer formulations and their use
11/12/2013US8580838 5-membered heterocycle-based p38 kinase inhibitors
11/12/2013US8580837 Parasiticidal formulation
11/12/2013US8580836 Plant disease control composition and method of controlling plant disease
11/12/2013US8580834 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/12/2013US8580833 Substituted imidazole derivatives and methods of use thereof
11/12/2013US8580832 Substituted phenoxy aminothiazolones as estrogen related receptor-α modulators
11/12/2013US8580831 Fluorinated aminotriazole derivatives
11/12/2013US8580830 Non-mucoadhesive film dosage forms
11/12/2013US8580829 Oxadiazole inhibitors of leukotriene production
11/12/2013US8580828 Mitotic kinesin inhibitors and methods of use thereof
11/12/2013US8580827 Anti-Francisella agents
11/12/2013US8580826 Hydroxybenzoate salts of metanicotine compounds
11/12/2013US8580825 Oxadiazole inhibitors of leukotriene production
11/12/2013US8580824 Pyridin-4-yl derivatives as immunomodulating agents
11/12/2013US8580823 Piperidine renin inhibitors
11/12/2013US8580822 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
11/12/2013US8580821 Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
11/12/2013US8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
11/12/2013US8580819 Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
11/12/2013US8580818 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
11/12/2013US8580817 1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
11/12/2013US8580816 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
11/12/2013US8580815 Derivatives of azaindoles as inhibitors of protein kinases ABL and SRC
11/12/2013US8580814 Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
11/12/2013US8580813 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
11/12/2013US8580812 Heteroaryl amide analogues as P2X7 antagonists
11/12/2013US8580811 Androgen receptor modulator methods
11/12/2013US8580810 Compounds and formulations suitable for radical scavenging
11/12/2013US8580809 Filamin A-binding anti-inflammatory analgesic
11/12/2013US8580808 Filamin A-binding anti-inflammatory analgesic
11/12/2013US8580807 Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
11/12/2013US8580806 Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
11/12/2013US8580805 Pyrimidine carboxamide derivatives
11/12/2013US8580804 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
11/12/2013US8580803 Substituted pyrrolo-aminopyrimidine compounds
11/12/2013US8580802 Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases
11/12/2013US8580801 Phosphodiesterase inhibitor treatment
11/12/2013US8580800 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
11/12/2013US8580798 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
11/12/2013US8580797 Compounds
11/12/2013US8580796 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/12/2013US8580795 Heterocyclic compounds as phosphodiesterase inhibitors
11/12/2013US8580794 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/12/2013US8580793 Use of kinase inhibitor for the treatment of thymoma
11/12/2013US8580792 Inhibitor compounds and cancer treatment methods
11/12/2013US8580791 Antiviral 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole bis-dihydrogen-phosphate salts
11/12/2013US8580790 (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors
11/12/2013US8580789 Treating glaucoma
11/12/2013US8580788 Opioid antagonists
11/12/2013US8580787 Compositions and methods for reducing activation of alpha-1 receptors
11/12/2013US8580786 Triazine derivatives and their therapeutical applications
11/12/2013US8580784 Method for treating a disease related to the glucocorticoid receptor
11/12/2013US8580783 [1,2,4]triazolo [1,5-c]pyrimidine derivatives as Hsp90 modulators
11/12/2013US8580782 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/12/2013US8580781 Pyridazinone derivatives
11/12/2013US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist
11/12/2013US8580779 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/12/2013US8580778 Substituted dihydropyrazolones and their use
11/12/2013US8580777 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa
11/12/2013US8580776 Compositions and methods for treating neurodegenerating diseases
11/12/2013US8580775 Use of derivatives of sinapinic acid and compositions comprising such derivatives
11/12/2013US8580774 Use of DHEA derivatives for enhancing physical performance
11/12/2013US8580773 Small-molecule inhibitors of the androgen receptor
11/12/2013US8580772 Combination therapies using melengestrol acetate and zilpaterol or its salts
11/12/2013US8580771 Dosage form for hormonal contraception
11/12/2013US8580770 Method of treating actinic keratosis and basal cell carcinoma
11/12/2013US8580769 Treatment of obesity, metabolic syndrome, and diabetes with protein kinase C inhibitors
11/12/2013US8580768 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
11/12/2013US8580767 Oxazolidinone containing dimer compounds, compositions and methods to make and use
11/12/2013US8580766 Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
11/12/2013US8580765 Nucleoside phosphoramidate prodrugs
11/12/2013US8580764 Combinational compositions and methods for treatment of cancer
11/12/2013US8580763 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
11/12/2013US8580762 Substituted purine and 7-deazapurine compounds
11/12/2013US8580761 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
11/12/2013US8580753 Modulation of telomere length in telomerase positive cells and cancer therapy
11/12/2013US8580752 Aromatic amides as potentiators of bioefficacy of anti-infective drugs
11/12/2013US8580751 Esterified α-galactosylceramide
11/12/2013US8580750 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
11/12/2013US8580743 Modified galectin 9 proteins and methods of treatment using them
11/12/2013US8580730 Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists
11/12/2013US8580553 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions
11/12/2013US8580533 Destructible surfactants and uses thereof
1 ... 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 ... 7860